Great Ormond Street Hospital (GOSH)’s mission is to provide world-class clinical care and training, pioneering new research and treatments, in partnership with others, for the benefit of children in the UK and worldwide.
Across our departments and divisions we have a shared vision to produce world leading translational and patient-orientated research. We are always aspiring to develop new research and treatments across the breadth of paediatric specialities. Great Ormond Street Hospital for Children is fully committed to conducting high quality research in collaboration with our various academic and industry partners.
At GOSH, our research teams are consistently amongst the best in the world in their disciplines. Our highly skilled researchers, with the support of the entire Trust’s workforce, are using cutting-edge techniques and equipment to:
Develop novel and improved diagnostics for our patients and the wider population.
Pioneering innovative treatments and therapies for our patients.
Performing high quality clinical trials of academic and industry-led medicines and therapeutics.
Understanding and preventing the development and progression of childhood illnesses.
Evaluating at a multi-disciplinary level the impact and progression of disease and our interventions.
and treatments, in partnership with others, for the benefit of children in the UK and worldwide.
With its broad range of clinical specialties, GOSH is in a unique position to undertake research into the most complex and rare childhood diseases. At any one time, there are several hundred active research projects ranging from observational studies to clinical trials of medicinal products. In collaboration with our colleagues at the Institute of Child Health, the Trust is currently involved with over 60 individual research groups dedicated to rare diseases.
GOSH also a site for one of the National Institute for Health Research (NIHR) Biomedical Research Centres (BRC). Great Ormond Street Hospital (GOSH) and the UCL Institute of Child Health were first awarded NIHR BRC status in 2007. A successful application in 2011 resulted in a further 5 years funding from 2012 to 2017. Find out more about our Biomedical Research Centre here.